A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| YM-298198 hydrochloride | YM-298198 hydrochloride is a high-affinity, selective, orally active, and non-competitive antagonist of metabotropic glutamate receptor type 1 (mGluR1). YM-298198 hydrochloride can be used for the research of neurological disorders [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1216398-09-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-103568. |  |
| YM298198 Hydrochloride (6-Amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide Hydrochloride) | A highly potent antagonist selective for mGlu1 receptors (IC50 = 16nM). Biologically active admitted orally or systematically. Often used in assessing the functional roles of mGlu1 receptors in a variety of research areas, such as anxiety and stress related disorders, analgesia, nociceptive pain, and schizophrenia. Group: Biochemicals. Grades: Highly Purified. CAS No. 748758-45-4. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| YM-30059 | YM-30059 is a quinolone antibiotic produced by Arthrobacter sp. YL-02729S. It shows anti-gram-positive bacterial activity and cytotoxicity. It also inhibits li poxygenase. Synonyms: YM 30059. Molecular formula: C19H25NO2. Mole weight: 299.4. |  |
| YM-32890 A | YM-32890 A is a macrolide antibiotic isolated from the fermentation broth of cytophaga sp. YL-02905S. It inhibits the growth of staphylococci including a macrolide-resistant strain, but shows no antimicrobial activity against other Gram-positive, Gram-negative bacteria and yeast. Synonyms: YM-32890A; YM-32890-A. Molecular formula: C33H48O6. Mole weight: 540.7. | |
| YM-32890 B | YM-32890 B is a macrolide antibiotic isolated from the fermentation broth of cytophaga sp. YL-02905S. Synonyms: YM-32890B; YM-32890-B. Molecular formula: C33H48O6. Mole weight: 540.7. | |
| YM-46303 | YM-46303 is an mAChR antagonist which had a binding affinity of 0.39 nM to M3-receptors. YM-46303 exhibits the highest affinities for M1 and M3 receptors. YM-46303 had been in phase II clinical trials by Astellas Pharma for the treatment of urinary incontinence. Synonyms: YM-46303; YM-46303; YM-46303; 1-azabicyclo[2.2.2]octan-4-yl N-(2-phenylphenyl)carbamate;hydrochloride. CAS No. 171722-81-9. Molecular formula: C20H23ClN2O2. Mole weight: 358.86. | |
| YM-47141 | YM-47141 is a cyclic-depsipeptide produced by Flexibacter sp. Q17897. It acts as an elastase inhibitor with IC50 of 1.5 X 10(-7) mol/L. Synonyms: YM 47141; N-(phenylacetyl)-L-phenylalanyl-N-[(3R,6S,9S,14S,17S,18R)-6-(2-amino-2-oxoethyl)-3,18-dimethyl-9,14-bis(2-methylpropyl)-2,5,8,11,12,13,16-heptaoxo-1-oxa-4,7,10,15-tetraazacyclooctadecan-17-yl]-L-threoninamide. Molecular formula: C46H62N8O13. Mole weight: 935. | |
| YM-47142 | YM-47142 is a cyclic-depsipeptide produced by Flexibacter sp. Q17897. It acts as an elastase inhibitor with IC50 of 3.0 X 10(-7) mol/L. Synonyms: YM 47142; N-(3-methylbutanoyl)-L-phenylalanyl-N-[(3R,6S,9S,14S,17S,18R)-6-(2-amino-2-oxoethyl)-3,18-dimethyl-9,14-bis(2-methylpropyl)-2,5,8,11,12,13,16-heptaoxo-1-oxa-4,7,10,15-tetraazacyclooctadecan-17-yl]-L-threoninamide. Molecular formula: C43H64N8O13. Mole weight: 901. | |
| YM-47515 | YM-47515 is an isonitrile antibiotic isolated from Micromonospora echinospora subsp. Echinospora. It is effective against gram-positive bacteria including MRSA. Synonyms: YM 47515. Molecular formula: C17H29NO4. Mole weight: 311.4. | |
| YM-47522 | YM-47522 is an antifungal antibiotic isolated from the culture broth of Bacillus sp. YL-03709B. It exhibited potent in vitro antifungal activity especially against Rhodotorula acuta and Pichia angusta (MIC = 0.05 and 0.75 mM/ml, respectively). It also showed moderate or weak antifungal activity against Candida albicans and Cryptococcus neoformans (MIC = 25 and 6.25 mM/ml, respectively). Synonyms: YM 47522. Molecular formula: C24H33NO4. Mole weight: 399.5. | |
| YM 511 | YM 511 is a potent aromatase (CYP19) inhibitor (IC50 = 0.4 and 0.12 nM at rat ovary and human placenta cells, respectively) that weakly inhibits the synthesis of other steroid hormones. YM 511 decreases plasma estrogen levels into ranges induced by ovariectomy and inhibits testosterone-induced breast cancer cell growth in vitro (IC50 = 0.13 nM). Synonyms: 4-[[(4-Bromophenyl)methyl]-4H-1,2,4-triazol-4-ylamino]benzonitrile; YM511; YM-511; YM 511. Grades: ≥99% by HPLC. CAS No. 148869-05-0. Molecular formula: C16H12BrN5. Mole weight: 354.2. | |
| Ym-53601 | YM-53601, a squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in vivo. YM-53601 inhibits squalene synthase derived from human hepatoma cells with an IC50 of 79 nM. Lipid-lowering agent. YM-53601 is also an inhibitor of farnesyl-diphosphate farnesyltransferase 1 (FDFT1) enzyme activity and abrogates HCV propagation. Group: Inhibitors. CAS No. 182959-33-7. Molecular formula: C21H21FN2O. Mole weight: 372.86. Appearance: Solid. Purity: 0.9926. Canonical SMILES: F/C (COC1=CC (NC2=C3C=CC=C2) =C3C=C1) =C4CN5CCC/4CC5. [H]Cl. Catalog: ACM182959337. |  |
| YM-53601 | YM-53601 is a squalene synthase inhibitor with IC50s of 79 and 90 nM in HepG2 cells and rat liver microsomes, respectively. It is a lipid lowering agent that can reduce plasma cholesterol and triglyceride levels in vivo and inhibit cholesterol biosynthesis in rats (ED50 = 32 mg/kg). It is also an inhibitor of farnesyl-diphosphate farnesyltransferase 1 (FDFT1) enzyme activity and can inhibit the proliferation of HCV. Synonyms: 9H-Carbazole, 2-[(2E)-2-(1-azabicyclo[2.2.2]oct-3-ylidene)-2-fluoroethoxy]-, hydrochloride (1:1); (E)-3-[2-(Carbazol-2-yloxy)-1-fluoroethylidene]quinuclidine hydrochloride; 2-[(2E)-2-(1-azabicyclo[2.2.2]oct-3-ylidene)-2-fluoroethoxy]-9H-carbazole, monohydrochloride. Grades: ≥98%. CAS No. 182959-33-7. Molecular formula: C21H21FN2O.HCl. Mole weight: 372.86. | |
| YM 58483 | YM 58483 is a calcium release-activated calcium (CRAC) channel inhibitor. YM 58483 suppresses thapsigargin-induced sustained Ca2+ influx (IC50 = 100 nM), cytokine production and proliferation of T cells in vitro. YM 58483 exhibits immuno-modulatory and anti-inflammatory activity. Synonyms: N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-1,2,3-thiadiazole-5-carboxamide; Btp2; YM-58483; YM 58483; CRAC Channel Inhibitor, BTP2. Grades: ≥99% by HPLC. CAS No. 223499-30-7. Molecular formula: C15H9F6N5OS. Mole weight: 421.32. | |
| YM 58483 | YM 58483. Group: Biochemicals. Grades: Highly Purified. CAS No. 223499-30-7. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| YM 60828 | YM 60828. Group: Biochemicals. Alternative Names: 2- [ [ [ [7- (Aminoiminomethyl) -2-naphthalenyl] methyl] [4- [ [1- (1-iminoethyl) -4-piperidinyl] oxy] phenyl] amino] sulfonyl] acetic acid dihydrochloride; [ [ [ [7- (Aminoiminomethyl) -2-naphthalenyl] methyl] [4- [ [1- (1-iminoethyl) -4-piperidinyl] oxy] phenyl] amino] sulfonyl] acetic acid dihydrochloride. Grades: Highly Purified. CAS No. 179755-65-8. Pack Sizes: 5mg, 10mg, 25mg. Molecular Formula: C27H33Cl2N5O5S. US Biological Life Sciences. | Worldwide |
| YM 750 | YM 750 is an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50 = 0.18 μM), displaying hypocholesterolaemic and antiatherosclerotic activity in vivo. Synonyms: YM 750; YM750; YM-750; N-Cycloheptyl-N-(9H-fluoren-2-ylmethyl)-N'-(2,4,6-trimethylphenyl)urea; ACAT inhibitors, Yamanouchi. Grades: ≥98% by HPLC. CAS No. 138046-43-2. Molecular formula: C31H36N2O. Mole weight: 452.63. | |
| YM758 | YM758 is a novel 'funny' If current channel (If channel) inhibitor which has a specific bradycardiac effect, and it is under development for the treatment of stable angina and atrial fibrillation. Synonyms: N-[2-[(3R)-3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl)piperidin-1-yl]ethyl]-4-fluorobenzamide; YM 758; YM-758; YM758 cpd. CAS No. 312752-85-5. Molecular formula: C26H32FN3O4. Mole weight: 469.55. | |
| YM 90709 | YM 90709 is an IL5 receptor antagonist. Synonyms: YM-90709; YM 90709; YM90709. 2,3-dimethoxy-6,6-dimethyl-5,6-dihydrobenzo(7,8)indolizino (2,3-b)quinoxaline. CAS No. 163769-88-8. Molecular formula: C22H21N3O2. Mole weight: 359.43. | |
| YM 90K hydrochloride | YM 90K hydrochloride is a selective AMPA receptor antagonist (Ki = 84, 2200 and > 37000 nM for AMPA, kainate and NMDA receptors, respectively). YM 90K hydrochloride displays neuroprotective activity that delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration. Synonyms: YM90K hydrochloride; YM 90 K hydrochloride; YM-90-K hydrochloride; YM90K HCl; YM-90-K HCl; YM 90 K HCl; 1,4-Dihydro-6-(1H-imidazol-1-yl)-7-nitro-2,3-quinoxalinedione hydrochloride. Grades: ≥99% by HPLC. CAS No. 154164-30-4. Molecular formula: C11H7N5O4.HCl. Mole weight: 309.67. | |
| YM 976 | Orally active PDE4 inhibitor (IC50 = 2.2 nM). Low emetogenic activity, suggested to be due to poor brain penetration. Group: Biochemicals. Grades: Highly Purified. CAS No. 191219-80-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| YM 976 | YM 976 is an orally bioactive PDE4 inhibitor (IC50 = 2.2 nM). YM 976 inhibits PDE4 to maintain cAMP and prolong signal transduction. Synonyms: YM976; YM 976; YM-976. 4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one. Grades: ≥98% by HPLC. CAS No. 191219-80-4. Molecular formula: C17H16ClN3O. Mole weight: 313.79. | |
| Y-(mPEG10K)2-(PEG20k-NH2) | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. |  |
| YMU1 | YMU1 is a human thymidylate kinase (hTMPK; IC50 value 1.65 μM) inhibitor yet not has inhibitory effect on the activity of purified thymidine kinase 1 (TK1). YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site. Synonyms: ethyl 4-[2-(4,6-dimethyl-3-oxo-[1,2]thiazolo[5,4-b]pyridin-2-yl)acetyl]piperazine-1-carboxylate. Grades: 99%. CAS No. 902589-96-2. Molecular formula: C17H22N4O4S. Mole weight: 378.45. | |
| YMU1 | YMU1 is a human thymidylate kinase (hTMPK) inhibitor that lacks inhibitory effect on the activity of purified thymidine kinase 1 (TK1). YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site. Blocking hTMPK by YMU1 attenuates the ATP binding-induced closed conformation that is required for phosphorylation of dTMP and sensitizes cancer cells for low-dose doxorubicin chemotherapy. Group: Inhibitors. Alternative Names: YMU1; YMU 1; YMU-1. CAS No. 902589-96-2. Molecular formula: C17H22N4O4S. Mole weight: 378.45. Appearance: Solid powder. Purity: >98%. IUPACName: ethyl 4-(2-(4,6-dimethyl-3-oxoisothiazolo[5,4-b]pyridin-2(3H)-yl)acetyl)piperazine-1-carboxylate. Canonical SMILES: O=C (N1CCN (C (CN2SC3=NC (C)=CC (C)=C3C2=O)=O)CC1)OCC. Catalog: ACM902589962. | |
| YN-0165J-A | YN-0165J-A is an enteromycin group antibiotic produced by Streptomyces strain YN-0165J. It is effective against Gram-positive and -negative bacteria, but is inactive to Enterobacter cloacae and Pseudomonas aeruginosa. CAS No. 102692-05-7. Molecular formula: C7H13N3O4. Mole weight: 203.2. | |
| YNYNGGVKSDLN | Synonyms: Tyr-Asn-Tyr-Asn-Gly-Gly-Val-Lys-Ser-Asp-Leu-Asn. Molecular formula: C58H86N16O21. Mole weight: 1343.42. | |
| Yoda 1 | Yoda 1 is a potent and selective Piezo1 agonist. Yoda 1 activates purified Piezo1 channels. Yoda 1 potently inhibits macropinocytosis induced by epidermal growth factor (EGF). Yoda 1 enhances Ca 2+ influx followed by activation of the calcium-activated potassium channel KCa3.1 and inhibition of Rac1 activation [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 448947-81-7. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-18723. | |
| Yoda 1 | Yoda 1 is a glycine transporters GLYT2 inhibitor as a novel agonist of the mechanotransduction channel Piezo1. Uses: Piezo1 channel activator. Synonyms: GlyT2-IN-1; Yoda1; Yoda-1; Yoda 1;2-[5-[[(2,6-Dichlorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]pyrazine;2-[(2,6-dichlorophenyl)methylsulfanyl]-5-pyrazin-2-yl-1,3,4-thiadiazole. Grades: ≥98 %. CAS No. 448947-81-7. Molecular formula: C13H8Cl2N4S2. Mole weight: 355.27. | |
| Yohimban-16-carboxylic acid,1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-,methyl ester, (3beta, 16beta, 17alpha, 18beta, 20alpha)-, [r-(r*, r*)]-2, 3-dihydroxybutanedionate | Heterocyclic Organic Compound. Alternative Names: Bietaserpine bitartrate;Tensibar. CAS No. 1111-44-0. Molecular formula: C39H53N3O9.C4H6O6. Catalog: ACM1111440. | |
| Yohimbe bark | Yohimbe bark. Group: Biochemicals. Alternative Names: Yohimbine. Grades: Highly Purified. CAS No. 146-48-5. Pack Sizes: 1g, 2g, 5g, 10g, 25g. US Biological Life Sciences. | Worldwide |
| Yohimbe Extract | Yohimbe Extract. Applications: Used for men health care products, dietary supplements, treat sexual impotence and sexual dysfunction. Group: Others. Synonyms: Yohimbe Extract; 65-19-0; Corynante Yohimbe. CAS No. 65-19-0. Purity: 8% Yohimbine by HPLC. Appearance: Red brown fine powder. Storage: 2 years under well storage situation and stored away from direct sun light. Source: Bark. Species: Corynante Yohimbe. Yohimbe Extract; 65-19-0; Corynante Yohimbe; plant extract. Pack: 25KG/Drum with double plastic bag of foodstuff inside. Cat No: EXTW-077. |  |
| Yohimbine Bark Extract (Ratio) | Yohimbine Bark Extract (Ratio). Group: Others. Purity: 4:1~20:1. Yohimbine Bark Extract (Ratio). Cat No: EXTW-053. | |
| Yohimbine Extract | Strengthening muscular tension, increasing energy metabolism of human body. Group: Material of medical care. Alternative Names: yohimbine extractive. CAS No. 65-19-0. Molecular formula: C21H26N2O3·HCL. Mole weight: 390.91. Appearance: low purity: brownish red powder; white to off-white fine powde. Catalog: ACM65190. | |
| Yohimbine HCl | Yohimbine HCl. Group: Biochemicals. Grades: Highly Purified. CAS No. 65-19-0. Pack Sizes: 2g, 5g, 10g, 25g, 50g. Molecular Formula: C21H26N2O3·HCl. US Biological Life Sciences. | Worldwide |
| Yohimbine HCL 8% & 98% HPLC | Yohimbine HCL 8% & 98% HPLC. |  CA, FL & NJ |
| Yohimbine Hydrochloride | Indole alkaloid with α2-adrenergic blocking activity. Mydriatic. Used in the treatment of neurological disorders. Group: Biochemicals. Grades: Highly Purified. CAS No. 65-19-0. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Yohimbine Hydrochloride | Yohimbine hydrochloride is an alpha-2 renal adenomatase receptor inhibitor, blocking pre- and post-contact alpha-2 renal adenomatase receptors, causing the release of renal adenoma and multiple sclerosis. Uses: Scientific research. Group: Natural products. CAS No. 65-19-0. Pack Sizes: 10 mM * 1 mL; 500 mg; 1 g. Product ID: HY-N0127. | |
| Yohimbine Hydrochloride (17alpha-Hydroxyyohimban-16alpha-carboxylic Acid methyl Ester Hydrochloride, alpha2-Adrenoceptor Antagonist, Yohimbine Hydrochloride) | A potent antagonist for alpha-2-adrenoceptors (pKi values are 8.52, 8.00 and 9.17 for human alpha-2a, alpha-2B and alpha-2C receptors respectively). Often used as pharmacological stressor in animal studies. Group: Biochemicals. Grades: Highly Purified. CAS No. 65-19-0. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Yohimbine (Methyl-13C; Methyl-D3 ester) | Isotope-labeled Metabolites2H 13C Labeled Compounds. Alternative Names: Yohimbine-[13C,D3]. CAS No. 1261254-59-4. Molecular formula: C2013CH23D3N2O3. Mole weight: 358.45. Catalog: ACM1261254594. | |
| Yokonolide A | It is produced by the strain of Streptomyces diastatochromogenes B59. It can inhibit the signal transduction of thaliphin. Synonyms: (1S, 4E, 6R, 6'R, 7S, 8R, 9R, 10R, 11S, 12S, 16E, 18S, 19S, 21S, 23R, 25R)-6, 7, 9, 11, 19-Pentahydroxy-6'-[(2R)-2-hydroxybutyl]-18-[(2S)-3-hydroxy-2-methylpropyl]-6, 8, 12, 25-tetramethyl-3-oxo-3', 4', 5', 6'-tetrahydrospiro[2, 22-dioxabicyclo[19.3.1]pentacosa-4, 16-diene-23, 2'-pyran]-10-yl 2,4,6-trideoxy-4-(dimethylamino)-alpha-L-lyxo-hexopyranoside. Molecular formula: C47H83NO14. Mole weight: 886.16. | |
| YOP Protein Tyrosine Phosphatase from Yersinia enterocolitica, Recombinant | Protein tyrosine phosphatases are a group of enzymes that remove phosphate groups from phosphorylated tyrosine residues on proteins. Protein tyrosine (pTyr) phosphorylation is a common post-translational modification that can create novel recognition motifs for protein interactions and cellular localization, affect protein stability, and regulate enzyme activity. As a consequence, maintaining an appropriate level of protein tyrosine phosphorylation is essential for many cellular functions. Tyrosine-specific protein phosphatases (PTPase; EC 3.1.3.48) catalyse the removal of a phosphate group attached to a tyrosine residue, using a cysteinyl-phosphate enzym...rentiation, transformation, and synaptic strengthening. Recombinant, expressed in e. coli, > 50 kda unit/ml, buffered aqueous glycerol solution. Applications: Used to release phosphate groups specifically from phosphotyrosine residues in proteins. Group: Enzymes. Synonyms: YOP Protein Tyrosine Phosphatase; Protein tyrosine phosphatase; Tyrosine-specific protein phosphatases; PTPase. PTPase. Activity: > 50,000 unit/mL. Stability: -20°C. Form: buffered aqueous glycerol solution. Source: E. coli. Species: Yersinia enterocolitica. YOP Protein Tyrosine Phosphatase; Protein tyrosine phosphatase; Tyrosine-specific protein phosphatases; PTPase. Cat No: NATE-0642. | |
| y-Oxo-1-pyrenebutanoic Acid-13C4 | y-Oxo-1-pyrenebutanoic Acid-13C4. Group: Biochemicals. Alternative Names: γ-Oxo-1-pyrenebutyric Acid-13C4; NSC 407628-13C4; β-(1-Pyrenoyl)propionic Acid-13C4; γ-Oxo-1-pyrenebutyric Acid-13C4. Grades: Highly Purified. Pack Sizes: 2.5mg. Molecular Formula: C1613C4H14O3, Molecular Weight: 306.29. US Biological Life Sciences. | Worldwide |
| Yparex | Yparex. Group: Polymers. | |
| Y-PEG40K-Acetaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Y-PEG-Acetaldehyde. Molecular formula: average Mn 40000. | |
| Y-PEG40K-Alkyne | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Y-PEG40K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Y-PEG-COOH. Molecular formula: average Mn 40000. | |
| Y-PEG40K-Fluorescein | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. ≥95%. | |
| Y-PEG40K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Y-PEG-MAL. Molecular formula: average Mn 40000. | |
| Y-PEG40K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Y-shape PEG Amine, Y-PEG-NH2. Molecular formula: average Mn 40000. | |
| Y-PEG40K-NHS | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Y-PEG-NHS. Molecular formula: average Mn 40000. | |
| Y-PEG40K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Y-PEG-Propionaldehyde. Molecular formula: average Mn 40000. | |
| YQA14 | YQA14 is a high affinity dopamine D3 receptor antagonist. YQA14 is anti-opioid addiction agent. YQA14 inhibits Morphine/Cocaine-induced conditioned place preference (CPP) in animals [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1221408-42-9. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-116181. | |
| YRGDS Fibronectin Fragment | YRGDS Fibronectin Fragment is an adhesion peptide, a fibronectin fragment which displays strong binding affinity to thrombin-stimulated platelets. Synonyms: H-Tyr-Arg-Gly-Asp-Ser-OH; YRGDS. Grades: 95%. CAS No. 134282-68-1. Molecular formula: C24H36N8O10. Mole weight: 596.59. | |
| YS 035 hydrochloride | YS 035 hydrochloride is a Ca 2+ antagonist on cellular uptake and mitochondrial efflux of calcium ions. YS 035 hydrochloride inhibits Ca 2+ uptake by muscle cells and inhibits Na + /Ca 2+ exchange ( K i =28 μM). YS 035 hydrochloride is a useful tool for research on the mitochondrial Ca 2+ transport [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 89805-39-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-100928. | |
| YS-035 hydrochloride | YS-035 hydrochloride is a Ca2+ blocker that strikingly prolongs cardiac action potentials via inhibiting pacemaker current and K+ outward currents. Synonyms: YS-035 hydrochloride; YS 035 hydrochloride; YS035 hydrochloride; N,N-Bis-(3,4-dimethoxyphenylethyl)-N-methylamine hydrochloride. CAS No. 89805-39-0. Molecular formula: C21H29NO4.HCl. Mole weight: 395.93. | |
| YS-035 hydrochloride | YS-035 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 89805-39-0. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| YS-121 | YS-121 is a dual inhibitor of mPGES-1 (IC50 = 3.9 μM) and 5-LO (IC50 = 4.1 μM). Synonyms: YS 121; YS121; 2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanyloctanoic acid. Grades: ≥98%. CAS No. 916482-17-2. Molecular formula: C20H26ClN3O2S. Mole weight: 408. | |
| YS-201 | YS-201, also known as Diperdipine, is a dihydropyridine-type calcium channel antagonist potentially for the treatment of angina pectoris and hypertension. Synonyms: Diperdipine; YS-201; YS201; YS 201; Epddnp. 3-O-ethyl 5-O-(2-piperidin-1-ylethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; diperdipine; EPDDNP; ethyl-2-(1-piperidino)ethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate. CAS No. 108852-42-2. Molecular formula: C24H31N3O6. Mole weight: 457.52. | |
| YS-49 | Anti-inflammatory agent; Antithrombotic; Antiplatelet; YS-49 protects cells from oxidant injury; induces heme oxygenase (HO-1) in endothelial cells and protects cells from oxidant injury; activator of PI3K/Akt signaling. Synonyms: YS 49; YS49. Grades: >98%. CAS No. 132836-42-1. Molecular formula: C20H20BrNO2. Mole weight: 386.28. | |
| YS-822A | YS-822A is a polyene macrolide antibiotic isolated from the culture filtrate of a mutant strain H-8 of Streptoverticillium eurocidicum var. asterocidicus S-822. It has antifungal activity with MIC of 3.12-12.5μg/mL for yeast. Synonyms: YS 822A; Antibiotic YS 822A; 10,29-Dioxabicyclo(23.3.1)nonacosa-15,17,19,21-tetraene-26-carboxylic acid, 23-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,27-pentahydroxy-11-(1-methylethyl)-9-oxo-. CAS No. 130767-46-3. Molecular formula: C37H59NO14. Mole weight: 741.9. | |
| Ysamber ® K | Ysamber ® K. CAS No. 154171-76-3. VIGON Item # 502547. Categories: Speciality Ingrdients Suppliers, Fragrances, amber spirolene, Perfumers. |  America & Internationally |
| YSZ Grinding Media | YSZ Grinding Media. Group: Magnetic nanoparticles. Alternative Names: YSZ Grinding Media. 99.9%. | |
| Ytterbium | Ytterbium. Uses: There is not much commercial use for ytterbium. radioactive ytterbium can be used for asmall portable x-ray source and as an alloy to make special types of strong steel. the oxides ofytterbium are used to make lasers and some synthetic gemstones. Group: 3d printing materials. Alternative Names: Yb; Ytterbium, wire reel, 50mm, diameter 1.0mm, square section, 99.9%; Ytterbium, wire reel, 200mm, diameter 1.0mm, square section, 99.9%; Ytterbium, plasma standard solution, Specpure(R), Yb 10,000microg/ml; Ytterbium, lump, 50g, max. size 25mm, 99.9%; YB2; I14-101278; Ytterbium, powder, 500 max. part. size (micron), weight 20 g, purity 99.9%; Ytterbium, powder, max. particle size 500 micron, weight 10 g, purity 99.9%; Ytterbium, chunks, 99.9% trace metals basis. CAS No. 7440-64-4. Product ID: ytterbium. Molecular formula: 173.054g/mol. Mole weight: Yb. [Yb]. InChI=1S/Yb. NAWDYIZEMPQZHO-UHFFFAOYSA-N. | |
| Ytterbium 2,4-pentanedionate | Ytterbium 2,4-pentanedionate. Grades: 99.9% Extremely High (>=99%). CAS No. 14284-98-1. Pack Sizes: Gram Quantities: 2 gm, 10 gm. Order Number: 3814. |  www.prochemonline.com |
| Ytterbium Acetate | Ytterbium Acetate. Grades: 99.9% Extremely High (>=99%). CAS No. 15280-58-7. Pack Sizes: Gram Quantities: 10 gm, 50 gm. Order Number: 3787. | www.prochemonline.com |
| Ytterbium Acetate | YTTERBIUM ACETATE, TETRAHYDRATE, 99.9% pure, -6 mesh, Formula: Yb(OOCCH3)3.4H2O. CAS No. 15280-58-7. Noah Chemicals San Antonio, Texas. ISO 9001:2015 Certified. Request a Quote Today! |  Texas TX |
| Ytterbium aluminide | Heterocyclic Organic Compound. CAS No. 12265-05-3. Molecular formula: Al2Yb. Mole weight: 227. Catalog: ACM12265053. | |
| Ytterbium Aluminum Garnet | Ytterbium Aluminum Garnet. Uses: Ytterbium aluminum garnet (ybag) is a promising optical crystal with solid-state laser and scintillation applications. Group: Nanoparticles. CAS No. 12005-22-0. Molecular formula: 846.02g/mol. Mole weight: Yb3Al5O12. | |
| YTTERBIUM ANTIMONIDE | Heterocyclic Organic Compound. Alternative Names: YTTERBIUM ANTIMONIDE;antimony, compound with ytterbium (1:1);Antimony, compd. with ytterbium (1:1);Einecs 234-891-4. CAS No. 12039-34-8. Molecular formula: SbYb. Mole weight: 294.8. Catalog: ACM12039348. | |
Our database is helping our users find suppliers everyday.
